The field of cancer endocrinology has increasingly recognized the critical influence of systemic host factors—including endocrine regulation and metabolic ...

LLY or NVO? With surging GLP-1 sales, oral obesity pills and diverging 2026 outlooks, the obesity drug race is entering a pivotal new phase.

Novo Nordisk announced plans to drastically reduce the list price of its versions, Wegovy, Ozempic and Rybelsus.

Tirzepatide is one of the drugs that has revolutionized the treatment of obesity and other conditions such as diabetes in recent years. Despite its clinical success, its precise molecular and cellular ...

Abstract: In recent years, precision medicine aims to enhance cancer treatment based on the molecular profile of individual tumors but identifying the most effective drug for a specific cancer type ...